← Research library

[Neurotensin NT (8- 13) dipeptide analog dilept increases the pain threshold and decreases the severity of morphine withdrawal syndrome in rats].

Animal research · 2013

What was studied
Rats; experimental pain and morphine withdrawal
Main finding
Dilept increased experimental pain thresholds and reduced morphine-withdrawal signs in rats. These findings are distinct from its small psychiatric pilot and occupational comparisons.

Pain threshold · 34% increase · p<0.01

Reported findings and study design

Rat tail-flick and morphine-withdrawal experiments; Dilept 1.6 mg/kg IP. Dependence induced with morphine 10–20 mg/kg IP for five days; 16 withdrawal signs scored.

Population or model Rats; experimental pain and morphine withdrawal

Results · Previously retrieved indexed abstract; numerical statements checked against the saved source text
MeasureResultComparison, timing and statistics
Pain threshold34% increasep<0.01
Withdrawal expression after single Dilept administration29.1% reductionp<0.01
Withdrawal expression after subchronic administration37.5% reductionp<0.01
Morphine analgesiaNo change with Dilept reported

Rat outcomes; not a human addiction-treatment regimen.

Source for these results ↗ · Reviewed 2026-10-29

Study limitations and source details

Study limitations

  • Preclinical findings do not establish human benefit or safety.
  • Abstract only. Full methods and independent replication remain unconfirmed.

Source details

Primary publication metadata and indexed abstract checked via Europe PMC; full methodological review pending.

Abstract reviewed

Sources checked

Citation

Animal / experimentalEnglish abstract

Konstantinopol'skiĭ MA, Cherniakova IV, Kudrin VS, Klodt PM, Kolik LG, Gudasheva TA. [Neurotensin NT (8- 13) dipeptide analog dilept increases the pain threshold and decreases the severity of morphine withdrawal syndrome in rats]. Eksperimental'naia i klinicheskaia farmakologiia

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards